These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 7579442

  • 1. Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors.
    Rosti V, Bergamaschi G, Lucotti C, Danova M, Carlo-Stella C, Locatelli F, Tonon L, Mazzini G, Cazzola M.
    Blood; 1995 Nov 01; 86(9):3387-93. PubMed ID: 7579442
    [Abstract] [Full Text] [Related]

  • 2. c-kit expression by CD34+ bone marrow progenitors and inhibition of response to recombinant human interleukin-3 following exposure to c-kit antisense oligonucleotides.
    Catlett JP, Leftwich JA, Westin EH, Grant S, Huff TF.
    Blood; 1991 Dec 15; 78(12):3186-91. PubMed ID: 1720696
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
    Szczylik C, Skórski T, Malaguarnera L, Hetman J, Chen ST, Calabretta B.
    Folia Histochem Cytobiol; 1996 Dec 15; 34(3-4):129-34. PubMed ID: 8967957
    [Abstract] [Full Text] [Related]

  • 4. c-abl function in normal and chronic myelogenous leukemia hematopoiesis: in vitro studies with antisense oligomers.
    Rosti V, Bergamaschi G, Ponchio L, Cazzola M.
    Leukemia; 1992 Jan 15; 6(1):1-7. PubMed ID: 1736009
    [Abstract] [Full Text] [Related]

  • 5. Effect of bcr-abl oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukaemia cells.
    de Fabritiis P, Skorski T, De Propris MS, Paggi MG, Nieborowska-Skorska M, Lisci A, Buffolino S, Campbell K, Geiser T, Calabretta B.
    Leukemia; 1997 Jun 15; 11(6):811-9. PubMed ID: 9177433
    [Abstract] [Full Text] [Related]

  • 6. Expression and physiologic significance of Kit ligand and stem cell tyrosine kinase-1 receptor ligand in normal human CD34+, c-Kit+ marrow cells.
    Ratajczak MZ, Kuczynski WI, Sokol DL, Moore JS, Pletcher CH, Gewirtz AM.
    Blood; 1995 Sep 15; 86(6):2161-7. PubMed ID: 7545021
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells.
    Weber-Nordt RM, Henschler R, Schott E, Wehinger J, Behringer D, Mertelsmann R, Finke J.
    Blood; 1996 Oct 01; 88(7):2549-58. PubMed ID: 8839847
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Growth of erythroid colonies in chronic myelogenous leukemia is independent of erythropoietin only in the presence of steel factor.
    Issaad C, Vainchenker W.
    Blood; 1994 Nov 15; 84(10):3447-56. PubMed ID: 7524739
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of the effect of bcr/abl breakpoint specific phosphothiorate oligodeoxynucleotides on colony formation by bcr/abl positive and negative, CD34 enriched mononuclear cell populations.
    Chasty R, Whetton A, Lucas G.
    Leuk Res; 1996 May 15; 20(5):391-5. PubMed ID: 8683978
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lineage-specific requirement of c-abl function in normal hematopoiesis.
    Caracciolo D, Valtieri M, Venturelli D, Peschle C, Gewirtz AM, Calabretta B.
    Science; 1989 Sep 08; 245(4922):1107-10. PubMed ID: 2672339
    [Abstract] [Full Text] [Related]

  • 16. Cationic lipid mediated transfer of c-abl and bcr antisense oligonucleotides to immature normal myeloid cells: uptake, biological effects and modulation of gene expression.
    Albrecht T, Schwab R, Peschel C, Engels HJ, Fischer T, Huber C, Aulitzky WE.
    Ann Hematol; 1996 Feb 08; 72(2):73-9. PubMed ID: 8597610
    [Abstract] [Full Text] [Related]

  • 17. Separation of myeloid and erythroid progenitors based on expression of CD34 and c-kit.
    De Jong MO, Wagemaker G, Wognum AW.
    Blood; 1995 Dec 01; 86(11):4076-85. PubMed ID: 7492763
    [Abstract] [Full Text] [Related]

  • 18. Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha.
    Valtieri M, Venturelli D, Caré A, Fossati C, Pelosi E, Labbaye C, Mattia G, Gewirtz AM, Calabretta B, Peschle C.
    Blood; 1991 Mar 15; 77(6):1181-90. PubMed ID: 1705831
    [Abstract] [Full Text] [Related]

  • 19. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW, Ruscetti FW, Gooya JM, Linnekin DM, Keller JR.
    Stem Cells; 1997 Mar 15; 15(1):63-72. PubMed ID: 9007224
    [Abstract] [Full Text] [Related]

  • 20. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.
    Muszynski KW, Ruscetti FW, Heidecker G, Rapp U, Troppmair J, Gooya JM, Keller JR.
    J Exp Med; 1995 Jun 01; 181(6):2189-99. PubMed ID: 7539043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.